Abstract

Diabetes mellitus presents a significant global health challenge, necessitating innovative approaches to enhance patient well-being. Traditional uniform treatment strategies have demonstrated limitations in addressing the heterogeneous nature of the disease. In recent times, personalized medicine has emerged as a revolutionary solution, tailoring treatment plans based on individual genetic profiles, lifestyle factors, and health attributes. It is firmly established through clinical trials that behavioral interventions have the potential to reduce the risk of progression from prediabetes to type 2 diabetes by half, yet the translation of this effective intervention into real-world applications at scale remains a persistent challenge. Genetic screening for predicting susceptibility to diabetes and gauging treatment response, combined with the integration of lifestyle adjustments and behavioral interventions, can empower patients on their health journey. Recent research has shed light on the pivotal role of epigenetic modifications in the onset and progression of Type 2 Diabetes (T2D), as well as the promise of functional foods as a complementary therapeutic approach for the disease. Looking ahead, personalized medicine holds the promise of becoming a cornerstone in the detection and management of diabetes, ensuring enhanced patient outcomes and fostering a more effective, globally centered approach to care.

Description